Bicillin L-A is a medicine containing the active ingredient(s) benzathine benzylpenicillin. On this page you will find out more about Bicillin L-A, including side effects, age restrictions, food interactions and whether the medicine is subsidised by the government on the pharmaceutical benefits scheme (PBS)
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional. healthdirect medicines information is not intended for use in an emergency. If you are suffering an acute illness, overdose, or emergency condition, call triple zero (000) and ask for an ambulance.
Reasonable care has been taken to provide accurate information at the time of creation. This information is not intended to substitute medical advice, diagnosis or treatment and should not be exclusively relied on to manage or diagnose a medical condition. Please refer to our terms and conditions.
Active ingredient in this medicine: benzathine benzylpenicillin
Information for medicine and pack size:
Bicillin L-A 1.2 million units (900 mg)/2 mL injection suspension, 5 x 2 mL syringes
Consumer Medicine Information leaflet:
This leaflet may also be found inside the medicine package. It contains information on side effects, age restrictions and other useful data.
What this medicine is for
Intramuscular benzathine penicillin is indicated in the treatment of infections due to penicillin-sensitive micro-organisms that are susceptible to the low and very prolonged serum levels common to this particular dosage form. Therapy should be guided by bacteriological studies (including sensitivity tests) and by clinical response. The following infections will usually respond to adequate dosage of intramuscular benzathine penicillin: Streptococcal infections (Group A - without bacteraemia). Mild-to-moderate infections of the upper respiratory tract (e.g. pharyngitis). Venereal infections - Syphilis, yaws, bejel and pinta. Medical conditions in which benzathine penicillin therapy is indicated as prophylaxis: Rheumatic fever and/or chorea - Prophylaxis with benzathine penicillin has proven effective in preventing recurrence of these conditions. It has also been used as a follow-up prophylactic therapy for preventing rheumatic heart disease and acute glomerulonephritis.
Table of characteristics
|Visual appearance||White fluid suspension|
|Dosage Form||Injection, suspension|
|Route of administration||Intramuscular|
10 pre-filled syringes: Prescription Only Medicine, or Prescription Animal Remedy
5 pre-filled syringes: Prescription Only Medicine, or Prescription Animal Remedy
There is one type of pack available.
Pack type 1
|Storage temperature||Store at 2 to 8 degrees Celsius|
|Storage conditions||Do not Freeze,Refrigerate|
|Life time||3 Years|
We were unable to verify that this medicine is available on the PBS (Pharmaceutical Benefits Scheme). Please consult your pharmacist if you need further information
The PBS provides a list of government subsidised medicines available to be dispensed to patients. Further information can be found on the Pharmaceutical Benefits Scheme website.
Is this medication banned in sport?
Check if you can use your medicine whilst playing sport. Search the Australian Sports Anti-Doping Authority (ASADA) database that provides information about the prohibited status of specific medications and/or the active ingredient based on the current World Anti-Doping Agency (WADA) Prohibited List.
Found 2 results
Bicillin L-A Suspension for injection - myDr.com.au
Bicillin L-A Suspension for injection - Consumer Medicines Information leaflets of prescription and over-the-counter medicines
Read more on myDr – Consumer Medicine Information website
Bicillin L-A (benzathine benzylpenicillin injection) information | myVMC
Bicillin L-A (benzathine benzylpenicillin injection) is used to treat infections in different parts of the body caused by bacteria and rheumatic fever.
Read more on myVMC – Virtual Medical Centre website
Found 0 results